Dan Sotolongo Jimenez in Miami Lakes, Florida

Home Florida Miami Lakes

Dan Sotolongo Jimenez has Family Practice as his primary medical specialty. Their primary office is: 14701 Nw 77th Ave in Miami Lakes, Florida. There are 9 additional office locations for Dan Sotolongo Jimenez that can be viewed towards the end of their profile.

They're a part of the: Criticare Clinics Inc medical group which has around 75 members. You can call their office at 305-665-4614 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2017 (around 7 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Dan Sotolongo Jimenez Office Phone and Directions

Dan Sotolongo Jimenez
Criticare Clinics Inc
14701 Nw 77th Ave
Miami Lakes, Florida 33014
305-665-4614

Patient Ratings
Please rate your experience with Dan Sotolongo Jimenez below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 305-665-4614

Enter a starting address:

Healthcare Info for Dan Sotolongo Jimenez

Medical School: Sorry, his university is not listed
Graduation Year: 2017
The Primary Medical Specialty for Dan Sotolongo Jimenez is listed as: Family Practice
Approximate Years of Experience: 7
PAC (PECOS ID)#: 9931460748
NPI #: 1245755958
NPI Created On: 08/03/2017
NPI Last Updated Listed as: 06/12/2023
Primary Taxonomy Code: 207Q00000X
License Number:
036153273
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $122

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 852631149

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: PRIMARY CARE

Name of Drug #1: NURTEC ODT

Open Associated Drug #1: 72618-3000-2